Clinical Trials - August 13, 2021
A3P Biomedical announces publication of its STHLM3 MRI trial
The company has announced that the publication of the trial including 12,750 men has been fast tracked and is now published in The Lancet Oncology. Results from the trial demonstrated that the combination of A3P Biomedical’s blood test Stockholm3 with Magnetic resonance imaging (MRI) in a population based prostate cancer screening program decreases unnecessary biopsies […]